Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7265 p298
6 September 2003

This page
Reprint
Photocopy

   

PDF* 100K

Letters

  Prescribing
  Storage temperatures
  CPD
  The Society
  The Journal


Letters to the Editor

Storage temperatures

Confusion remains over drug stability to heat

From Mr C. Polwart, MRPharmS

The news article “Hot weather no risk to medicine stocks” (PJ, 16 August, p195) was misleading and provided little valuable help to pharmacists, leaving more questions unanswered than it actually addressed. It is hardly helpful to reassure pharmacists that unnamed pharmaceutics experts say “most medicines are tested to meet the requirements of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use” (ICH). Most pharmacists will already be aware that there is unlikely to be any major effect from short-term exposure to temperatures greater than 25C for most of their stock. The problem remains that there will be a minority of stock that can not withstand this exposure.

The difficulty for pharmacists is identifying which drugs will be affected in order that they can be protected in the first place, or if necessary destroyed. The ICH website provides details regarding the testing but no indication of which products have been tested, and as the Association of the British Pharmaceutical Industry spokeswoman points out, medicines should be stored as listed in their product licence. Are we to call the manufacturer for every item stocked in our pharmacies to check if they have stability data at higher temperatures? Even if manufacturers do have data they will always be at pains to stress that the use of a product that has been stored outside its licensed storage conditions is no longer licensed and the user takes legal responsibility.

Although the ICH standard dictates that refrigerator lines should be able to withstand exposure at 25C for six months a brief review of data held on the Guy’s and St Thomas’ NHS Refrigeration Database, suggests that for many refrigerated products this is not the case, which leads me to wonder what proportion of tablets tested to ICH also fail to meet the standard. Is there an easy way to identify which products fail to meet the ICH standard?

Much of the article concentrated on the storage of tablets and topical products, it failed to consider the storage of liquids and injections, where the risk of hydrolysis is much greater and where the effects of temperature accelerate the reaction. Additionally temperatures above 30C, which have been recorded for a number of days in some parts of the country, provide ideal conditions for incubation of microbiological contamination in opened containers of liquids and suspensions.

Is it now time for the Society’s Code of Ethics to incorporate a requirement for validation of temperatures for drugs stored at room temperature as well as for drugs stored in refrigerators, rather than the current statement? Such a requirement is necessary for pharmaceutical wholesalers, licensed through the MHRA.1 There is an easier way for pharmacies to avoid concerns about drug storage — install air conditioning. Many pharmacies already have air conditioning and many others will be able to maintain temperatures below 30C throughout the year without the need to install air conditioning. For the remainder, where temperatures regularly rise above 25C and often peak at over 30C, how sure can we be that every one of the products on our shelves remains within its limits throughout its use? Or will it be legitimate to cite the news article in The Journal, as evidence that the products are safe when exposed to temperatures of 40C?

Perhaps the most burning question that arises from this article is why the PJ chose to publish an article entitled “Hot weather no risk to medicine stocks” the same week that the Society published a press release to patients warning them “the summer heat could damage their medicines”? Who are we to believe — the PJ or the Society?

Calum Polwart
Durham

References
1. Taylor J. Recommendations on the control and monitoring of storage and transportation temperatures of medicinal products. Pharm J 2001;267:128–31 (PDF 65K)

Send your letter to The Editor

Previous Topic (Prescribing)
Next Topic (CPD)

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal